8 August 2019 - Cancer care advocate Malcolm Mulholland says he has been inundated with messages of excitement and rejoice following news PHARMAC is considering funding three new drugs.

On Wednesday, PHARMAC - the country's drug funding agency - announced it is considering funding Alecensa, which treats lung cancer, Kadcyla, which treats breast cancer, and Ocrevus for relapsing multiple sclerosis.

Read Newshub article